[go: up one dir, main page]

IL125197A0 - 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof having cns activity - Google Patents

4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof having cns activity

Info

Publication number
IL125197A0
IL125197A0 IL12519796A IL12519796A IL125197A0 IL 125197 A0 IL125197 A0 IL 125197A0 IL 12519796 A IL12519796 A IL 12519796A IL 12519796 A IL12519796 A IL 12519796A IL 125197 A0 IL125197 A0 IL 125197A0
Authority
IL
Israel
Prior art keywords
dihydronaphth
isoxazoles
derivatives
cns activity
cns
Prior art date
Application number
IL12519796A
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of IL125197A0 publication Critical patent/IL125197A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL12519796A 1996-01-05 1996-12-12 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof having cns activity IL125197A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (1)

Publication Number Publication Date
IL125197A0 true IL125197A0 (en) 1999-03-12

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12519796A IL125197A0 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof having cns activity

Country Status (14)

Country Link
EP (1) EP0874833A1 (en)
JP (1) JP3161737B2 (en)
KR (1) KR100308748B1 (en)
CN (1) CN1214046A (en)
AR (1) AR005347A1 (en)
AU (1) AU710059B2 (en)
BR (1) BR9612578A (en)
CA (1) CA2241845C (en)
HU (1) HUP9903706A3 (en)
IL (1) IL125197A0 (en)
NO (1) NO983100L (en)
NZ (1) NZ325587A (en)
WO (1) WO1997025317A1 (en)
ZA (1) ZA9725B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8656101A (en) * 2000-08-21 2002-03-04 Univ Georgetown 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
KR20040093061A (en) * 2002-04-02 2004-11-04 얀센 파마슈티카 엔.브이. Substituted amino isoxazoline derivatives and their use as anti-depressants
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
ATE456568T1 (en) 2002-08-15 2010-02-15 Janssen Pharmaceutica Nv CONDENSED HETEROCYCLIC ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTIDEPRESSANTS
AU2003271567B2 (en) * 2002-08-21 2009-12-24 Janssen Pharmaceutica N.V. C6- and C9-substituted chromeno (4, 3-C) isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
KR20130036171A (en) 2009-10-29 2013-04-11 브리스톨-마이어스 스큅 컴퍼니 Tricyclic heterocyclic compounds
ES2859478T3 (en) 2016-09-02 2021-10-04 Bristol Myers Squibb Co Substituted tricyclic heterocyclic compounds
WO2019032632A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company Alkylphenyl compounds
WO2019032631A1 (en) 2017-08-09 2019-02-14 Bristol-Myers Squibb Company OXIME ETHER COMPOUNDS
KR102002633B1 (en) 2018-07-19 2019-07-22 김태효 Non slip foot wear with separating cushion part

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
DK0402644T3 (en) * 1989-05-19 1996-01-02 Hoechst Roussel Pharma N- (Aryloxyalkyl) heteroaryl piperidines and heteroaryl piperazines, process for their preparation and their use as medicaments
JPH08502958A (en) * 1992-10-23 1996-04-02 メルク シヤープ エンド ドーム リミテツド Dopamine receptor subtype ligand

Also Published As

Publication number Publication date
AR005347A1 (en) 1999-04-28
EP0874833A1 (en) 1998-11-04
ZA9725B (en) 1997-07-07
AU710059B2 (en) 1999-09-09
AU1412697A (en) 1997-08-01
CN1214046A (en) 1999-04-14
JPH11510816A (en) 1999-09-21
CA2241845A1 (en) 1997-07-17
HUP9903706A2 (en) 2000-08-28
JP3161737B2 (en) 2001-04-25
BR9612578A (en) 1999-07-27
KR19990077033A (en) 1999-10-25
NO983100D0 (en) 1998-07-03
CA2241845C (en) 2002-10-01
HUP9903706A3 (en) 2000-09-28
KR100308748B1 (en) 2001-12-12
NZ325587A (en) 1999-02-25
NO983100L (en) 1998-09-04
WO1997025317A1 (en) 1997-07-17

Similar Documents

Publication Publication Date Title
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
ZA977687B (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
ZA976222B (en) N-(4-aryl-thiazol-2-yl)-sulphonamide derivatives and their use.
IL126968A0 (en) Alkylaminobenzothiazole and benzoxazole derivatives
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
GB9411088D0 (en) Hydroxylamine derivatives
IL125197A0 (en) 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof having cns activity
HUP9902901A3 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans
PL330141A1 (en) Novel derivatives of 10,11-dihydro-10-oxo-5h-dibezyl(b,f)-azepin-5-carboxagmide
HUP9901875A3 (en) Isoxazolidine derivatives
HRP970162A2 (en) 1,25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives
PL315809A1 (en) Derivatives of 1,3,2-benzothiazole monoxide
GB9807808D0 (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
ZA9510694B (en) 1 3 4-oxadiazine derivatives
IL129029A0 (en) 8(9)-Dehydroestradiol derivatives
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole
PL332044A1 (en) 25-methylene and 24,25-epoxy marcphortines and paraherquamides
TW335862U (en) Muffler (3)
TW326873U (en) Muffler (2)
PL330590A1 (en) Novel derivatives of 7-bromo- and 7,7-dibromocephame and cepheme
AU942P (en) WOORIKEE 2000 Isopogon anemonifolius